FindTrial
Sign In

Comparison between Andrographis paniculate and Individualize Homoeopathic Medicine in treatment of Metabolic Associated Fatty Liver Disease

Effectiveness of Andrographis paniculata versus Individualized Homoeopathic Medicines in management of Metabolic Associated Fatty Liver Disease a prospective randomized comparative study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094641
Enrollment
68
Registered
2025-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: Andrographis paniculata: Pill form of administration Oral route of administration 30 pill size Centesimal scale First dose after case taking Repetition of dose according to follow up In

Sponsors

Bakson Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants with grade 1 grade 2 metabolic associated fatty liver disease All genders participating aged 18 to 59 years Participants with lft report ast 0 to 111 iu per l alt 0 to 126 iu per l get 0 to 114 iu per l and triglycerides 40 to 400 mg per dl Participants who have willingly joined the study and signed the written informed consent Participants taking prior oral will be enrolled after a wash out period of 15 Days

Exclusion criteria

Exclusion criteria: Participants with any severe uncontrolled pre diagnose systemic illness Participant with liver fibrosis cirrhosis and malignancy Participants with uncontrolled htn dm or immunocompromised individuals Participants those who have undergone liver transplant Participants with high alcohol consumption more than 140g per week for men more than 70g per week for women and active smoker smoking more than 10 pack per year Pregnant and lactating mothers Participants with any psychiatric illness

Design outcomes

Primary

MeasureTime frame
To compare the changes in the Fatty Liver Index activities pre and post homoeopathic medicines.Timepoint: 16 months study 6 month enrolment 6 month follow up 4 month report writing Fatty liver index is use statistical analysis done at beginning 3 month 6 month—

Secondary

MeasureTime frame
To compare the effectiveness of these medicines in the management of MAFLD using Hepatic Steatosis Index and Short form 36 health related quality of life scores as outcome measures.Timepoint: 16 months study 6 month enrolment 6 month follow up 4 month report writing Hepatic Steatosis Index is use Short form 36 questionnaire is use statistical analysis done at beginning 3 month 6 month—

Countries

India

Contacts

Public ContactDr Ashwini Nair

Bakson Homoeopathic Medical College and Hospital

pginchargebakson@gmail.com9990178024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026